Stephen B. Fox
Impact in
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Cancer Research 166
- Cancer Genomics and Diagnostics 71
- Breast Cancer Treatment Studies 48
- Cancer, Hypoxia, and Metabolism 44
- Oncology 163
- Cancer Immunotherapy and Biomarkers 35
- Co-authors
- Adrian L. Harris (97 shared papers)Russell Leek (19 shared papers)Kevin C. Gatter (27 shared papers)Alexander Dobrovic (32 shared papers)Roy Bicknell (12 shared papers)Alison H. Banham (12 shared papers)Helen Turley (22 shared papers)Ruth M. Whitehouse (8 shared papers)
- Journals
- The Journal of Pathology (31 papers)Histopathology (24 papers)Breast Cancer Research and Treatment (22 papers)British Journal of Cancer (22 papers)Breast Cancer Research (21 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Stephen B. Fox
474 papers receiving 35.5k citations
Stephen B. Fox's Hit Papers
Peers
Comparison fields: 5 of 192
- Cancer Research 9.4k
- Oncology 14.1k
- Reproductive Medicine 1.6k
- Molecular Biology 13.0k
- Otorhinolaryngology 737
Countries citing papers authored by Stephen B. Fox
This map shows the geographic impact of Stephen B. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen B. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen B. Fox more than expected).
Fields of papers citing papers by Stephen B. Fox
This network shows the impact of papers produced by Stephen B. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen B. Fox. The network helps show where Stephen B. Fox may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen B. Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 485 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome Hit paper breakdown → | 2008 | 1179 |
| 2 | Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Hit paper breakdown → | 2009 | 1162 |
| 3 | Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study Hit paper breakdown → | 2012 | 1082 |
| 4 | Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse Hit paper breakdown → | 2006 | 1003 |
| 5 | BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group Hit paper breakdown → | 2012 | 974 |
| 6 | Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis Hit paper breakdown → | 2018 | 805 |
| 7 | Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Hit paper breakdown → | 1997 | 745 |
| 8 | Breast cancer prognostic classification in the molecular era: the role of histological grade Hit paper breakdown → | 2010 | 707 |
| 9 | Lymphangiogenesis and lymphatic vessel remodelling in cancer Hit paper breakdown → | 2014 | 667 |
| 10 | Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation Hit paper breakdown → | 1996 | 663 |
| 11 | The 2019 World Health Organization classification of tumours of the breast Hit paper breakdown → | 2020 | 640 |
| 12 | Prognostic Significance of p16 INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial Hit paper breakdown → | 2010 | 637 |
| 13 | Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors Hit paper breakdown → | 2017 | 629 |
| 14 | Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research Hit paper breakdown → | 2017 | 553 |
| 15 | Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists Hit paper breakdown → | 2010 | 550 |
| 16 | Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA) Hit paper breakdown → | 2012 | 529 |
| 17 | 2002 | 402 | |
| 18 | 1995 | 392 | |
| 19 | 2011 | 379 | |
| 20 | 1995 | 356 |
About Stephen B. Fox
Stephen B. Fox is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 485 papers that have together received 36.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (71 papers), Angiogenesis and VEGF in Cancer (58 papers), Breast Cancer Treatment Studies (48 papers), Cancer, Hypoxia, and Metabolism (44 papers), Cancer Immunotherapy and Biomarkers (35 papers), Lung Cancer Treatments and Mutations (29 papers), BRCA gene mutations in cancer (29 papers) and Genetic factors in colorectal cancer (28 papers). The work is most often cited by research in Cancer Research (9.4k citations), Oncology (14.1k citations), Reproductive Medicine (1.6k citations), Molecular Biology (13.0k citations) and Otorhinolaryngology (737 citations). Stephen B. Fox has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Adrian L. Harris, Russell Leek, Kevin C. Gatter, Alexander Dobrovic, Roy Bicknell, Alison H. Banham, Helen Turley, Ruth M. Whitehouse, Gaynor J. Bates and David D.L. Bowtell. Their work appears in journals such as The Journal of Pathology, Histopathology, Breast Cancer Research and Treatment, British Journal of Cancer and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.